Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group - Moore, M J; Goldstein, D; Hamm, J (Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2007)
et al.